1. Home
  2. MIRM vs DIOD Comparison

MIRM vs DIOD Comparison

Compare MIRM & DIOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIRM
  • DIOD
  • Stock Information
  • Founded
  • MIRM 2018
  • DIOD 1959
  • Country
  • MIRM United States
  • DIOD United States
  • Employees
  • MIRM 334
  • DIOD N/A
  • Industry
  • MIRM Biotechnology: Pharmaceutical Preparations
  • DIOD Semiconductors
  • Sector
  • MIRM Health Care
  • DIOD Technology
  • Exchange
  • MIRM Nasdaq
  • DIOD Nasdaq
  • Market Cap
  • MIRM 2.2B
  • DIOD 2.2B
  • IPO Year
  • MIRM 2019
  • DIOD N/A
  • Fundamental
  • Price
  • MIRM $44.86
  • DIOD $44.41
  • Analyst Decision
  • MIRM Strong Buy
  • DIOD Buy
  • Analyst Count
  • MIRM 12
  • DIOD 2
  • Target Price
  • MIRM $63.17
  • DIOD $54.00
  • AVG Volume (30 Days)
  • MIRM 397.1K
  • DIOD 483.7K
  • Earning Date
  • MIRM 05-07-2025
  • DIOD 05-08-2025
  • Dividend Yield
  • MIRM N/A
  • DIOD N/A
  • EPS Growth
  • MIRM N/A
  • DIOD N/A
  • EPS
  • MIRM N/A
  • DIOD 0.55
  • Revenue
  • MIRM $379,251,000.00
  • DIOD $1,341,261,000.00
  • Revenue This Year
  • MIRM $33.98
  • DIOD $10.90
  • Revenue Next Year
  • MIRM $16.19
  • DIOD $7.36
  • P/E Ratio
  • MIRM N/A
  • DIOD $80.64
  • Revenue Growth
  • MIRM 69.31
  • DIOD N/A
  • 52 Week Low
  • MIRM $23.83
  • DIOD $32.93
  • 52 Week High
  • MIRM $54.23
  • DIOD $86.74
  • Technical
  • Relative Strength Index (RSI)
  • MIRM 56.31
  • DIOD 50.71
  • Support Level
  • MIRM $43.30
  • DIOD $43.85
  • Resistance Level
  • MIRM $44.57
  • DIOD $46.76
  • Average True Range (ATR)
  • MIRM 1.20
  • DIOD 1.26
  • MACD
  • MIRM -0.05
  • DIOD -0.38
  • Stochastic Oscillator
  • MIRM 54.57
  • DIOD 10.35

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

About DIOD Diodes Incorporated

Diodes Inc is a manufacturer and supplier of high-quality application-specific products within the broad discrete, logic, analog, and mixed-signal semiconductor markets. It serves the customer electronics, computing, communications, industrial, and automotive markets. The Company's products include diodes; rectifiers; transistors; MOSFETs; GPP bridges; GPP rectifiers; protection devices; function-specific arrays; single gate logic; amplifiers and comparators; Hall-effect and temperature sensors; and power management devices, including LED drivers, AC-DC converters and controllers, DC-DC switching and linear voltage regulators, voltage references along with special-function devices, such as USB power switches, load switches, voltage supervisors, and motor controllers.

Share on Social Networks: